Work

Molecular pharmacology and antitumor activity of PX-866, a novel inhibitor of phosphoinositide-3-kinase signaling

Year: 2004

Type: article

Source: Molecular Cancer Therapeutics

DOI: 10.1158/1535-7163.763.3.7

Authors: Nathan T. Ihle, Ryan Williams, Sherry Chow, Wade Chew, Margareta I. Berggren, Gillian Paine-Murrieta, Daniel J. Minion, Robert J. Halter, Peter Wipf, Robert Abraham, Lynn Kirkpatrick, Garth Powis

Institutions: University of Arizona, University of Arizona Cancer Center, University of Pittsburgh, Sanford Burnham Prebys Medical Discovery Institute

Language: English

Topic: PI3K/AKT/mTOR signaling in cancer

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: Redox Signaling and Cancer Drug Action, THIOREDOXIN REDUCTASES AND CANCER, G3975975021, THIOREDOXIN AND ANTICANCER DRUG ACTION, G6172355312, G8685244982

OpenAlex ID: W2162584257

FWCI: 4.703

Cites: 49

Cited by: 318

Related to: 10